Researchers at the University of British Columbia (UBC) and BC Cancer, in partnership with BC Children’s Hospital Research Institute (BCCHR), have developed a new test to more easily diagnose medulloblastoma, the most common malignant childhood brain tumour.
Scientists had previously noted that the presence of a large protein called MondoA was associated with worse outcomes in several pediatric cancers, but they didn’t understand why.
For Media
Every day, our researchers are working towards breakthroughs to transform the lives of kids in British Columbia and around the world. Learn about the latest innovations and advancements in child health.